KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,420,851 | $23,312,795 | 1.26% |
| Logos Global Management LP | 900,000 | $8,667,000 | 1.16% |
| Vivo Capital, LLC | 856,008 | $8,243,357 | 0.90% |
| Boxer Capital, LLC | 1,650,000 | $15,889,500 | 0.85% |
| Affinity Asset Advisors, LLC | 278,292 | $2,679,952 | 0.75% |
| AlphaCentric Advisors LLC | 135,000 | $1,300,050 | 0.74% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 228,934 | $2,204,634 | 0.67% |
| Birchview Capital, LP | 40,000 | $385,200 | 0.33% |
| Ghost Tree Capital, LLC | 100,000 | $963,000 | 0.32% |
| Ikarian Capital, LLC | 142,692 | $1,374,124 | 0.16% |
External links
This page lists KALVISTA PHARMACEUTICALS INC's shareholders in Q3 2023. To view KALVISTA PHARMACEUTICALS INC's shareholder history, click here.